Does FOSTAMATINIB Cause Urinary tract infection? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Urinary tract infection have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 1.6% of all adverse event reports for FOSTAMATINIB.
105
Reports of Urinary tract infection with FOSTAMATINIB
1.6%
of all FOSTAMATINIB reports
9
Deaths
39
Hospitalizations
How Dangerous Is Urinary tract infection From FOSTAMATINIB?
Of the 105 reports, 9 (8.6%) resulted in death, 39 (37.1%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which FOSTAMATINIB Alternatives Have Lower Urinary tract infection Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM